Heart Failure Treatment Device
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
240
NCT06455371
Patient-centered Dosage of Levothyroxine
Phase: N/A
Role: Collaborator
Start: Dec 20, 2024
Completion: Dec 31, 2027
Loading map...